Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
Lantheus (LNTH) Gets a Buy From Truist Financial
Lantheus Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Qiagen (QGEN)
Goldman Sachs Initiates Lantheus(LNTH.US) With Buy Rating, Announces Target Price $143
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating
Buy Rating Reaffirmed for Lantheus Amid Discounted Valuation and Promising Growth Catalysts
TD Cowen Maintains Lantheus(LNTH.US) With Buy Rating, Cuts Target Price to $110
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
A Quick Look at Today's Ratings for Lantheus(LNTH.US), With a Forecast Between $112 to $122
Lantheus Holdings Is Maintained at Market Outperform by JMP Securities
Lantheus Holdings Analyst Ratings
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating
JMP Securities Maintains Lantheus(LNTH.US) With Buy Rating, Cuts Target Price to $112
Lantheus: Strong Growth Potential Amid Challenges With Buy Rating Endorsement
JonesTrading Maintains Lantheus(LNTH.US) With Buy Rating, Cuts Target Price to $123
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating
Jefferies Maintains Lantheus(LNTH.US) With Buy Rating, Maintains Target Price $145
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating
Jefferies Maintains Lantheus(LNTH.US) With Buy Rating, Maintains Target Price $145